Welcure Drugs & Pharmaceuticals Ltd share price
You have to be logged in to add this to Watchlist.- ₹0.29(0.00%)May 15, 2026 15:52:27 PM IST
- NSE
- BSE
- Vol : 6.09 M (NSE + BSE)Last 20 day avg : 7.65 M
Welcure Drugs & Pharmaceuticals Ltd is trading 0.00% upper at Rs 0.29 as compared to its last closing price. Welcure Drugs & Pharmaceuticals Ltd has been trading in the price range of 0.30 & 0.28. Welcure Drugs & Pharmaceuticals Ltd has given -30.95% in this year & -6.45% in the last 5 days. Welcure Drugs & Pharmaceuticals Ltd has TTM P/E ratio 1.08 as compared to the sector P/E of 24.31.The company posted a net profit of 1.07 Crores in its last quarter.Listed peers of Welcure Drugs & Pharmaceuticals Ltd include Dr Reddy's Laboratories (2.62%), Cipla (-0.49%), Sun Pharmaceutical Industries (0.90%).The Mutual Fund holding in Welcure Drugs & Pharmaceuticals Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Welcure Drugs & Pharmaceuticals Ltd was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 15, 2026, 10:32 AM UTC
- BetaMedium volatility0.92Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.20The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.35The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values0.74Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.01The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Dr Reddy's Laboratories | Bullish | 1,336.95 | 2.62 | 1,11,584.24 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Moderately Bullish | 1,431.55 | -0.49 | 1,16,013.10 | 22.95 | 3.87 | 0.87 | 0.81 |
| Sun Pharmaceutical Industries | Bullish | 1,879.90 | 0.90 | 4,51,076.67 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,386.00 | -0.52 | 1,48,148.92 | 67.32 | 17.1 | 0.83 | 17.62 |
| Divi's Laboratories | Bullish | 6,755.00 | -2.41 | 1,78,679.99 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-12 | Quarterly Results |
| 2025-12-05 | Right Issue of Equity Shares |
| 2025-11-27 | To consider raisinf of funds |
| 2025-11-13 | Quarterly Results |
| 2025-09-27 | Others |
- IndustryBiotechnology & Drugs
- ISININE331C01025
- BSE Code524661
- NSE Code
Welcure Drugs & Pharmaceuticals Ltd is trading at 0.29 as on Fri May 15 2026 10:22:27. This is 0.00% upper as compared to its previous closing price of 0.29.
The market capitalization of Welcure Drugs & Pharmaceuticals Ltd is 35.84 Cr as on Fri May 15 2026 10:22:27.
The 52 wk high for Welcure Drugs & Pharmaceuticals Ltd is 1.44 whereas the 52 wk low is 0.23
Welcure Drugs & Pharmaceuticals Ltd can be analyzed on the following key metrics -
- TTM P/E: 1.08
- Sector P/E: 24.31
- Dividend Yield: 0.00%
- D/E ratio: -
Welcure Drugs & Pharmaceuticals Ltd reported a net profit of 2.17 Cr in 2025.
EQUITY QUICK LINKS
Welcure Drugs & Pharmaceuticals Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.